These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 12227210)

  • 1. Update on managing hypercholesterolemia. The new NCEP guidelines.
    Kuhar MB
    AAOHN J; 2002 Aug; 50(8):360-4. PubMed ID: 12227210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
    Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
    Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options.
    Stone NJ; Bilek S; Rosenbaum S
    Am J Cardiol; 2005 Aug; 96(4A):53E-59E. PubMed ID: 16098845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heart of the matter. National guidelines urge more aggressive cholesterol treatment.
    Leake NB
    Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511
    [No Abstract]   [Full Text] [Related]  

  • 5. Rising to the challenge of the new NCEP ATP III guidelines: exceeding current therapeutic limitations.
    Brewer HB
    Am J Manag Care; 2002 Feb; 8(2 Suppl):S23-8; discussion S45-7. PubMed ID: 11855698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol management: guidelines have changed, although diet is still central.
    Stoy DB
    AAOHN J; 1994 Mar; 42(3):102-7. PubMed ID: 8147994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
    Talbert RL
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.
    Arch Intern Med; 1988 Jan; 148(1):36-69. PubMed ID: 3422148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol treatment guidelines update.
    Safeer RS; Ugalat PS
    Am Fam Physician; 2002 Mar; 65(5):871-80. PubMed ID: 11898959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia.
    Persell SD; Lloyd-Jones DM; Baker DW
    J Gen Intern Med; 2006 Feb; 21(2):171-6. PubMed ID: 16390501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCEP's new guidelines at a glance. National Cholesterol Education Program.
    Benedict M
    Health Care Food Nutr Focus; 2002 Aug; 18(12):8-9. PubMed ID: 12192777
    [No Abstract]   [Full Text] [Related]  

  • 12. Adult treatment panel III and the management of dyslipidemia risk factors.
    Stein EA
    Postgrad Med; 2002 Oct; 112(4 Suppl):12-7. PubMed ID: 19667595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding cholesterol and its role in heart disease.
    Evered A
    Nurs Times; 2007 Jan 9-15; 103(2):28-9. PubMed ID: 17278732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
    Rosenson R; Lloyd-Jones D;
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity of lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment among the elderly before and after the 2004 National Cholesterol Education Program Adult Treatment Panel III update.
    Nichols GA; Nag S; Chan W
    Am Heart J; 2007 Sep; 154(3):554-60. PubMed ID: 17719305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Cheng AY; Leiter LA
    Curr Opin Cardiol; 2006 Jul; 21(4):400-4. PubMed ID: 16755211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and management of vascular risk: beyond low density lipoprotein cholesterol.
    Ross JL; Manuszak MA; Wachs JE
    AAOHN J; 2003 Dec; 51(12):521-31; quiz 532-3. PubMed ID: 14680155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.